{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:13:14Z","timestamp":1790745194546,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japan Society for the Promotion of Science (JSPS) KAKEN","award":["18 H02337"],"award-info":[{"award-number":["18 H02337"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13071-019-3520-x","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:03:39Z","timestamp":1559034219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo"],"prefix":"10.1186","volume":"12","author":[{"given":"Amani Magdy","family":"Beshbishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"3520_CR1","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.ijpara.2008.03.001","volume":"38","author":"KP Hunfeld","year":"2008","unstructured":"Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol. 2008;38:1219\u201337.","journal-title":"Int J Parasitol."},{"key":"3520_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.exppara.2016.04.015","volume":"166","author":"MD Baldissera","year":"2016","unstructured":"Baldissera MD, Grando TH, Souza CF, Cossetin LF, Sagrillo MR, Atia Nascimento K, et al. Nerolidol nanospheres increases its trypanocidal efficacy against Trypanosoma evansi: new approach against diminazene aceturate resistance and toxicity. Exp Parasitol. 2016;166:144\u20139.","journal-title":"Exp Parasitol."},{"key":"3520_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.phrs.2015.10.005","volume":"102","author":"GL da Silva Oliveira","year":"2015","unstructured":"da Silva Oliveira GL, de Freitas RM. Diminazene aceturate\u2014an antiparasitic drug of antiquity: advances in pharmacology & therapeutics. Pharmacol Res. 2015;102:138\u201357.","journal-title":"Pharmacol Res."},{"key":"3520_CR4","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","volume":"343","author":"PJ Krause","year":"2000","unstructured":"Krause PJ, Lepore T, Sikand VK, Gadbaw J, Burke G, Telford SR, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 2000;343:1454\u20138.","journal-title":"N Engl J Med."},{"key":"3520_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/AAC.02347-14","volume":"59","author":"JL Guler","year":"2015","unstructured":"Guler JL, White IJ, Phillips MA, Rathod PK. Atovaquone tolerance in Plasmodium falciparum parasites selected for high-level resistance to a dihydroorotate dehydrogenase inhibitor. Antimicrob Agents Chemother. 2015;59:686\u20139.","journal-title":"Antimicrob Agents Chemother."},{"key":"3520_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4269\/ajtmh.2006.74.593","volume":"74","author":"A Matsuu","year":"2006","unstructured":"Matsuu A, Miyamoto K, Ikadai H, Okano S, Higuchi S. Short report: cloning of the Babesia gibsoni cytochrome B gene and isolation of three single nucleotide polymorphisms from parasites present after atovaquone treatment. Am J Trop Med. 2006;74:593\u20137.","journal-title":"Am J Trop Med."},{"key":"3520_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.01175-08","volume":"53","author":"PN Soh","year":"2009","unstructured":"Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez MC, Berry A, et al. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother. 2009;53:1100\u20136.","journal-title":"Antimicrob Agents Chemother."},{"key":"3520_CR8","first-page":"92","volume":"11","author":"HM Zhang","year":"2014","unstructured":"Zhang HM, Zhao L, Li H, Xu H, Chen WW, Tao L. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med. 2014;11:92\u2013100.","journal-title":"Cancer Biol Med."},{"key":"3520_CR9","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3748\/wjg.14.3672","volume":"14","author":"M Edderkaoui","year":"2008","unstructured":"Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Liang V, Go W, et al. Ellagic acid induces apoptosis through inhibition of nuclear factor kB in pancreatic cancer cells. World J Gastroenterol. 2008;14:3672\u201380.","journal-title":"World J Gastroenterol."},{"key":"3520_CR10","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1021\/jf011275g","volume":"50","author":"KI Priyadarsini","year":"2002","unstructured":"Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem. 2002;50:2200\u20136.","journal-title":"J Agric Food Chem."},{"key":"3520_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jopan.2010.05.011","volume":"25","author":"S Corbett","year":"2010","unstructured":"Corbett S, Daniel J, Drayton R, Field M, Steinhardt R, Garrett N. Evaluation of the anti-inflammatory effects of ellagic acid. J Peri Anesthesia Nurs. 2010;25:214\u201320.","journal-title":"J Peri Anesthesia Nurs."},{"key":"3520_CR12","doi-asserted-by":"publisher","first-page":"e45906","DOI":"10.1371\/journal.pone.0045906","volume":"7","author":"PN Soh","year":"2012","unstructured":"Soh PN, Witkowski B, Gales A, Huyghe E, Berry A, Pipy B, et al. Implication of glutathione in the in vitro antiplasmodial mechanism of action of ellagic acid. PLoS ONE. 2012;7:e45906.","journal-title":"PLoS ONE."},{"key":"3520_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.phymed.2017.04.013","volume":"30","author":"R Aminu","year":"2017","unstructured":"Aminu R, Ibrahim MA, Rahman MA, Dash R, Umar IA. Trypanosuppresive effects of ellagic acid and amelioration of the trypanosome-associated pathological features coupled with inhibitory effects on trypanosomal sialidase in vitro and in silico. Phytomedicine. 2017;30:67\u201373.","journal-title":"Phytomedicine."},{"key":"3520_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00210-017-1387-y","volume":"390","author":"MMM Alves","year":"2017","unstructured":"Alves MMM, Brito LM, Souza AC, Queiroz BCSH, de Carvalho TP, Batista JF, et al. Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major. Naunyn Schmiedebergs Arch Pharmacol. 2017;390:893\u2013903.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"3520_CR15","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.2147\/IJN.S147740","volume":"12","author":"FM Mady","year":"2017","unstructured":"Mady FM, Shaker MA. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles. Int J Nanomed. 2017;12:7405\u201317.","journal-title":"Int J Nanomed"},{"key":"3520_CR16","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3390\/molecules22122175","volume":"22","author":"H Wang","year":"2017","unstructured":"Wang H, Zhang Y, Tian Z, Ma J, Kang M, Ding C, et al. Preparation of \u03b2-CD-ellagic acid microspheres and their effects on HepG2 cell proliferation. Molecules. 2017;22:2175.","journal-title":"Molecules."},{"key":"3520_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ijpharm.2010.08.033","volume":"400","author":"J Duan","year":"2010","unstructured":"Duan J, Zhang Y, Han S, Chen Y, Li B, Liao M, et al. Synthesis and in vitro\/in vivo anti-cancer evaluation of curcumin-loaded chitosan\/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm. 2010;400:211\u201320.","journal-title":"Int J Pharm."},{"key":"3520_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11095-006-9207-y","volume":"24","author":"K Sonaje","year":"2007","unstructured":"Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Kumar MN. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res. 2007;24:899\u2013908.","journal-title":"Pharm Res."},{"issue":"Suppl. 1","key":"3520_CR19","doi-asserted-by":"publisher","first-page":"S-860","DOI":"10.1016\/S0016-5085(11)63573-7","volume":"140","author":"YN Chudasama","year":"2011","unstructured":"Chudasama YN, Lugea A, Lu QY, Pandol SJ. Beta-cyclodextrin increases bioavailability of ellagic acid in rats. Gastroenterol. 2011;140(Suppl. 1):S-860.","journal-title":"Gastroenterol."},{"key":"3520_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s11051-012-0757-0","volume":"14","author":"M Kakran","year":"2012","unstructured":"Kakran M, Sahoo NG, Tan IL, Li L. Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods. J Nanopart Res. 2012;14:757.","journal-title":"J Nanopart Res."},{"key":"3520_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bbagen.2013.10.038","volume":"1840","author":"OS Adeyemi","year":"2014","unstructured":"Adeyemi OS, Whiteley CG. Interaction of metal nanoparticles with recombinant arginine kinase from Trypanosoma brucei: thermodynamic and spectrofluorimetric evaluation. Biochim Biophys Acta. 2014;1840:701\u20136.","journal-title":"Biochim Biophys Acta."},{"key":"3520_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1292\/jvms.59.479","volume":"59","author":"A Avarzed","year":"1997","unstructured":"Avarzed A, Igarashi I, Kanemaru T, Hirumi K, Omata Y, Saito A, et al. Improved in vitro cultivation of Babesia caballi. J Vet Med Sci. 1997;59:479\u201381.","journal-title":"J Vet Med Sci."},{"key":"3520_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1006\/expr.1998.4331","volume":"90","author":"I Igarashi","year":"1998","unstructured":"Igarashi I, Njonge FK, Kaneko Y, Nakamura Y. Babesia bigemina: In vitro and in vivo effects of curdlan sulfate on the growth of parasites. Exp Parasitol. 1998;90:290\u20133.","journal-title":"Exp Parasitol."},{"key":"3520_CR24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.ttbdis.2018.04.019","volume":"9","author":"DS Tayebwa","year":"2018","unstructured":"Tayebwa DS, Tuvshintulga B, Guswanto A, Nugraha AB, Batiha GES, Gantuya S, et al. The effects of nitidine chloride and camptothecin on the growth of Babesia and Theileria parasites. Ticks Tick Borne Dis. 2018;9:1192\u2013201.","journal-title":"Ticks Tick Borne Dis."},{"key":"3520_CR25","first-page":"335","volume":"119","author":"H Lengauer","year":"2006","unstructured":"Lengauer H, Just FT, Edelhofer R, Pfister K. Tick infestation and the prevalence of Borrelia burgdorferi and Babesia divergens in cattle in Bavaria. M\u00fcnch Tier\u00e4rztl Wochenschr. 2006;119:335\u201341.","journal-title":"M\u00fcnch Tier\u00e4rztl Wochenschr."},{"key":"3520_CR26","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1128\/IAI.67.8.4143-4148.1999","volume":"67","author":"I Igarashi","year":"1999","unstructured":"Igarashi I, Suzuki R, Waki S, Tagawa YI, Seng S, Tum S, et al. Roles of CD4+ T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infect Immun. 1999;67:4143\u20138.","journal-title":"Infect Immun."},{"key":"3520_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.parint.2010.06.004","volume":"59","author":"YK Goo","year":"2010","unstructured":"Goo YK, Terkawi MA, Jia H, Aboge GO, Ooka H, Nelson B, et al. Artesunate, a potential drug for treatment of Babesia infection. Parasitol Int. 2010;59:481\u20136.","journal-title":"Parasitol Int."},{"key":"3520_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpddr.2018.02.005","volume":"8","author":"A Guswanto","year":"2018","unstructured":"Guswanto A, Nugraha AB, Tuvshintulga B, Tayebwa DS, Rizk MA, Batiha GES, et al. 17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice. Int J Parasitol Drugs Drug Resist. 2018;8:104\u201311.","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"3520_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"T-C Chou","year":"2006","unstructured":"Chou T-C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58:621\u201381.","journal-title":"Pharmacol Rev."},{"key":"3520_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.molstruc.2015.08.054","volume":"1105","author":"DV Bulani","year":"2016","unstructured":"Bulani DV, Kothavade SP, Kundaikar SH, Gawali BN, Chowdhury AA, Degani SM, et al. Inclusion complex of ellagic acid with b-cyclodextrin: characterization and in vitro anti-inflammatory evaluation. J Mol Struct. 2016;1105:308\u201315.","journal-title":"J Mol Struct."},{"key":"3520_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.idc.2008.03.010","volume":"22","author":"E Vannier","year":"2008","unstructured":"Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin North Am. 2008;22:469\u201388.","journal-title":"Infect Dis Clin North Am."},{"key":"3520_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.vetpar.2006.01.048","volume":"138","author":"HJ Vial","year":"2006","unstructured":"Vial HJ, Gorenflot A. Chemotherapy against babesiosis. Vet Parasitol. 2006;138:147\u201360.","journal-title":"Vet Parasitol."},{"key":"3520_CR33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1517\/14656566.3.8.1109","volume":"3","author":"LM Weiss","year":"2002","unstructured":"Weiss LM. Babesiosis in humans: a treatment review. Expert Opin Pharmacother. 2002;3:1109\u201315.","journal-title":"Expert Opin Pharmacother."},{"key":"3520_CR34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2174\/092986712799828355","volume":"19","author":"J Mosqueda","year":"2012","unstructured":"Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem. 2012;19:1504\u201318.","journal-title":"Curr Med Chem."},{"key":"3520_CR35","doi-asserted-by":"publisher","first-page":"012028","DOI":"10.1088\/1742-6596\/784\/1\/012028","volume":"784","author":"SG Kolesnikova","year":"2017","unstructured":"Kolesnikova SG, Moiseeva IY. Prospects for the use of animal cell cultures in screening of pharmaceutical substances. J Phys Conf Ser. 2017;784:012028.","journal-title":"J Phys Conf Ser."},{"key":"3520_CR36","first-page":"219","volume":"77","author":"TV Galnbek","year":"2013","unstructured":"Galnbek TV, Akinshina GT. Modern trends and development of cell biotechnology in veterinary medicine. Res Inst Exper Veter Med. 2013;77:219\u201327.","journal-title":"Res Inst Exper Veter Med"},{"key":"3520_CR37","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jnutbio.2004.06.004","volume":"15","author":"JN Losso","year":"2004","unstructured":"Losso JN, Bansode RR, Trappey A, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem. 2004;15:672\u20138.","journal-title":"J Nutr Biochem."},{"key":"3520_CR38","first-page":"1829","volume":"33","author":"JH Weisburg","year":"2013","unstructured":"Weisburg JH, Schuck AG, Reiss SE, Wolf BJ, Fertel SR, Zuckerbraun HL, et al. Ellagic acid, a dietary polyphenol, selectively cytotoxic to HSC-2 oral carcinoma cells. Anticancer Res. 2013;33:1829\u201336.","journal-title":"Anticancer Res."},{"key":"3520_CR39","doi-asserted-by":"publisher","first-page":"13888","DOI":"10.1038\/s41598-017-14304-0","volume":"7","author":"B Tuvshintulga","year":"2017","unstructured":"Tuvshintulga B, AbouLaila M, Sivakumar T, Tayebwa DS, Gantuya S, Naranbaatar K, et al. Chemotherapeutic efficacies of a clofazimine and diminazene aceturate combination against piroplasm parasites and their AT-rich DNA-binding activity on Babesia bovis. Sci Rep. 2017;7:13888.","journal-title":"Sci Rep."},{"key":"3520_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.vetpar.2014.05.023","volume":"204","author":"M AbouLaila","year":"2014","unstructured":"AbouLaila M, Batadoj D, Salama A, Munkhjargal T, Ichikawa-Seki M, Terkawi MA, et al. Evaluation of the inhibitory effects of miltefosine on the growth of Babesia and Theileria parasites. Vet Parasitol. 2014;204:104\u201310.","journal-title":"Vet Parasitol."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3520-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3520-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3520-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:23:14Z","timestamp":1590535394000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3520-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3520"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3520-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiment was conducted in accordance with the Regulations for Animal Experiments of Obihiro University of Agriculture and Veterinary Medicine, Japan (animal experiment accession number: 290168).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}